Company intelligence / Profile preview

SoluBest

Ness Ziona, Central, Israelzoominfo.com ↗

Ownership: Private
Development stage: Preclinical

Overview

SoluBest developed proprietary nanoformulations and polymer-based drug delivery technologies to improve solubility and bioavailability of poorly soluble drugs. Their lead technology, Solumer™, demonstrated significant improvements in dissolution rates and absorption in preclinical studies. The company focused on reformulating off-patent drugs for its own pipeline as well as through co-development partnerships with pharma companies such as Dr. Reddy’s Laboratories and Particle Sciences. No late-stage clinical results are publicly available.

Therapeutic areas: Other
Modalities: Polymer-drug conjugate therapyNanoparticleSmall molecule
Industry: Biotech

Partnerships

Dr. Reddy's Laboratories Ltd.Particle Sciences Inc.multinational food, beverage, healthcare companies (via licensing out technology for cannabinoid products)

Beyond the preview

Go deeper on SoluBest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SoluBest.

Explore the full profile